TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
PCVX

Vaxcyte Inc

Healthcare · Biotechnology

58.10$ -3.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement PCVX
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
+18.8% +14.0% +28.1% +410.9% +715.6% -78.9%
+135.8% +51.3% +61.3% +6.6% +116.1% +96.1% +43.4% +66.6%
+6.7% +58.6% +87.4% +57.7% +57.6% +52.5% +53.1% +39.3%
+104.2% +48.9% +66.6% +17.6% +124.0% +101.5% +21.7% +62.2%
-46.7% -82.5% +0.0% -71.4% -100.0%
-47.3% -143.3% +230,685.7% -2,590.0%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?